AAAAAA

   
Results: 1-7 |
Results: 7

Authors: RACE E GILBERT SM SHELDON JG ROSE JSL MOFFATT AR SITBON G DISSANAYEKE SR CAMMACK N DUNCAN IB
Citation: E. Race et al., CORRELATION OF RESPONSE TO TREATMENT AND HIV GENOTYPIC CHANGES DURINGPHASE-III TRIALS WITH SAQUINAVIR AND REVERSE-TRANSCRIPTASE INHIBITOR COMBINATION THERAPY, AIDS, 12(12), 1998, pp. 1465-1474

Authors: TOMLINSON PW CRAIG JC MOFFATT AR ROBERTS NA SHELDON JG WHITTAKER L DUNCAN IB
Citation: Pw. Tomlinson et al., HIV-1 FROM PATIENTS IN A PHASE-II CLINICAL-TRIAL WITH THE PROTEINASE-INHIBITOR (PI) SAQUINAVIR (SQV) TAKEN IN COMBINATION WITH RT INHIBITORS (RTIS) EXHIBITS VERY LITTLE REDUCED SENSITIVITY TO OTHER PIS, AIDS, 10, 1996, pp. 12-12

Authors: GILBERT SM JUPP R MOFFATT AR SHELDON JG RACE E
Citation: Sm. Gilbert et al., IN-VITRO SELECTION OF HIV-1 VARIANTS WITH REDUCED SENSITIVITY TO SAQUINAVIR AND RITONAVIR BY SUCCESSIVE SEQUENTIAL PASSAGE, AIDS, 10, 1996, pp. 14-14

Authors: RACE E GILBERT SM SHELDON JG MOFFAT AR TOMLINSON PW DUNCAN IB
Citation: E. Race et al., LOW OCCURRENCE OF REDUCED SENSITIVITY TO SAQUINAVIR IN ANTIVIRAL COMBINATION - RESULTS FROM A PHASE-III CLINICAL-TRIAL (NV-14256), AIDS, 10, 1996, pp. 15-15

Authors: WHITTAKER L SCHAPIRO JM CRAIG JC WINTERS MA TOMLINSON PW SHELDON JG MOFFATT AR JACOBSEN H DUNCAN IB GILBERT S CRAWFORD S MERIGAN TC
Citation: L. Whittaker et al., AN ASSESSMENT OF PHENOTYPIC AND GENOTYPIC CORESISTANCE TO INHIBITORS OF HIV PROTEINASE FOLLOWING THERAPY WITH HIGH-DOSE SAQUINAVIR, AIDS, 10, 1996, pp. 17-17

Authors: RACE E GILBERT SM SHELDON JG MOFFAT AR TOMLINSON PW DUNCAN IB
Citation: E. Race et al., AN OVERVIEW OF DRUG-RESISTANCE DURING SAQUINAVIR TREATMENT, AIDS, 10, 1996, pp. 25-25

Authors: SHELDON JG WILLIAMS SP FULTON AM BRINDLE KM
Citation: Jg. Sheldon et al., P-31 NMR MAGNETIZATION-TRANSFER STUDY OF THE CONTROL OF ATP TURNOVER IN SACCHAROMYCES-CEREVISIAE, Proceedings of the National Academy of Sciences of the United Statesof America, 93(13), 1996, pp. 6399-6404
Risultati: 1-7 |